AmplexDiagnostics and Scope Biosciences are proud to introduce a groundbreaking solution in molecular diagnostics. In a new ...
UCLA researchers squeezed cells for milliseconds to briefly loosen their DNA, mapped where the DNA opened and aimed CRISPR ...
ERS Genomics Limited ('ERS Genomics'), the CRISPR licensing company, today announced that it has signed a non-exclusive ...
Peter Mac scientists have developed a way to precisely target the "unique molecular fingerprint" created when two genes ...
In this interview, Prof. Samuel Sternberg discusses how studies of CRISPR-Cas systems led to the discovery of RNA-guided DNA ...
Austin, June 11, 2025 (GLOBE NEWSWIRE) -- CRISPR Technology Market Size & Growth Analysis: According to SNS Insider, the global CRISPR Technology Market was valued at USD 3.45 billion in 2023 and is ...
AI and machine learning are revolutionizing CRISPR technology, enhancing precision and efficiency in gene editing, paving the way for breakthroughs in genetic research and therapy. In a groundbreaking ...
Scientists have long used a powerful gene-editing tool called CRISPR to make precise changes to DNA. But a different version ...
A 2026 review summarizes advances in CRISPR-Cas9 precision, delivery and primary-cell engineering for genetic diseases and ...
According to MarketsandMarkets™, the CRISPR Market is projected to reach USD 6.12 billion by 2031 from USD 3.48 billion in ...
Last year, a ten-month-old baby in the US was the first person in the world to have their rare genetic disease effectively cured through the use of CRISPR gene editing technology. But the rollout of ...
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) falls more steeply than broader market: What investors need to know
CRISPR Therapeutics AG (CRSP) ended the recent trading session at $49.21, demonstrating a -4.48% change from the preceding day's closing price. This change lagged the S&P 500's daily loss of 1.09%.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results